Haemonetics Corporation

Haemonetics Corporation

World Rank (Aug-2026)
4113
Market Cap (Aug-2026)
4.131 Billion USD
Market Cap (Mar-08-2026)
2.980 Billion USD
World Rank (Jan-05-2024)
3,403
Market Cap (Jan-05-2024)
4.151 Billion USD
World Rank (Jul-30-2023)
3,137
Market Cap (Jul-30-2023)
4.707 Billion USD
World Rank (Jan-07-2022)
5,235
Market Cap (Jan-07-2022)
2.690 Billion USD
World Rank (Jan-01-2021)
2,531
Market Cap (Jan-01-2021)
6.030 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
HAE
Employee Count
3,034
Employee Count as of Date
As on 2022
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1,334 Million USD
Annual Operating Income in USD
157 Million USD
Annual Net Income in USD
97 Million USD
Annual Results for Period Ending
For year ending March-2026
Total Assets in USD
2,396 Million USD
Total Liabilities in USD
1,600 Million USD
Total Equity in USD
796 Million USD
Balance Sheet for Period Ending
As of March-2026
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Company Website
HAEMONETICS CORPORATION
Yahoo
Yahoo @ NYSE
Company Profile

Haemonetics Corporation is a Blood Management Solution company. The company products are surgical and diagnostic devices and blood and plasma center devices. It services are education and change management and process improvement. The headquarters is in USA.

Annual Results Summary

HAEMONETICS CORPORATION - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Mar-20231,168156115
Mar-20229937143
Mar-20218705779
Mar-202098815376
Mar-20199678355
Balance Sheet Summary

Total Assets as on Mar-2023 was 1,934 Million USD.

Total Liabilities as on Mar-2023 was 1,116 Million USD.

Total Equity as on Mar-2023 was 817 Million USD.

Founded Year
1971
IPO Year
1991
Stock Exchange
NYSE
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share